FDA recalls 9,000 vials of cancer medicine Gemmis
Staff writer, with CNA
The Food and Drug Administration (FDA) yesterday said it has ordered TTY Biopharm Co Ltd (台灣東洋藥品) to recall 9,000 vials of a cancer drug after they were found to have been contaminated by extraneous material.
The drug, Gemmis Injection, is sold in 38ml vials and is usually used in combination with other medicines, such as gemcitabine and paclitaxel, to treat cancer of the lungs, pancreas, bladder or breast in specific cases, the FDA said.
The FDA urged people using Gemmis not to stop using it on their own and to ask their doctor to prescribe alternate medication.